Rezolute, Inc. SEC filings RZLT
Rezolute, Inc. has 759 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form 10-K, was filed on Sep 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DRS | Filing | Oct 15, 2026 | — |
| EFFECT | Filing | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 1, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| EFFECT | Filing | Aug 14, 2024 | — |
| CORRESP | Letter to the SEC | Aug 13, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2024 | — |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2023 | — |
| EFFECT | Filing | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 7, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| EFFECT | Filing | Jul 1, 2022 | — |
| CORRESP | Letter to the SEC | Jun 29, 2022 | — |
| EFFECT | Filing | Jun 24, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| 8-A12B/A | Filing | Jun 21, 2021 | — |
| 8-K12B | Form 8-k12b | Jun 21, 2021 | Jun 14, 2021 |
| EFFECT | Filing | Jan 6, 2021 | — |
| CORRESP | Letter to the SEC | Dec 29, 2020 | — |
| EFFECT | Filing | Nov 27, 2020 | — |
| CORRESP | Letter to the SEC | Nov 23, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2020 | — |
| CERT | Filing | Nov 9, 2020 | — |
| 8-A12B | Filing | Nov 4, 2020 | — |
| D | Filing | Oct 22, 2020 | — |
| NT 10-K | Filing | Sep 29, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Dec 6, 2019 | — |
| CORRESP | Letter to the SEC | Dec 4, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| EFFECT | Filing | Sep 18, 2019 | — |
| CORRESP | Letter to the SEC | Sep 16, 2019 | — |
| PRER14A | Filing | Sep 16, 2019 | — |
| CORRESP | Letter to the SEC | Sep 12, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2019 | — |
| CORRESP | Letter to the SEC | Sep 9, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2019 | — |
| PRER14A | Filing | Mar 28, 2019 | — |
| CORRESP | Letter to the SEC | Mar 28, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2019 | — |
| CT ORDER | Filing | Mar 18, 2019 | — |
| SC 14F1 | Filing | Jan 31, 2019 | — |
| NT 10-K | Filing | Oct 1, 2018 | Oct 1, 2018 |
| CT ORDER | Filing | Jun 25, 2018 | — |
| D/A | Filing | Apr 24, 2018 | — |
| CT ORDER | Filing | Mar 15, 2018 | — |
| D | Filing | Feb 15, 2018 | — |
| EFFECT | Filing | Feb 13, 2018 | — |
| CORRESP | Letter to the SEC | Feb 9, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2018 | — |
| D/A | Filing | Feb 7, 2018 | — |
| D | Filing | Jan 11, 2018 | — |
| EFFECT | Filing | Nov 8, 2017 | — |
| CORRESP | Letter to the SEC | Nov 7, 2017 | — |
| CORRESP | Letter to the SEC | Nov 7, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2017 | — |
| CORRESP | Letter to the SEC | Oct 31, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2017 | — |
| CORRESP | Letter to the SEC | Oct 13, 2017 | — |
| PRER14A | Filing | Oct 13, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2017 | — |
| D | Filing | May 31, 2017 | — |
| D | Filing | Feb 14, 2017 | — |
| SC TO-I/A | Filing | Feb 3, 2017 | — |
| EFFECT | Filing | Jan 19, 2017 | — |
| CORRESP | Letter to the SEC | Jan 17, 2017 | — |
| SC TO-I/A | Filing | Dec 27, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2016 | — |
| SC TO-I | Filing | Dec 15, 2016 | — |
| EFFECT | Filing | Oct 24, 2016 | — |
| EFFECT | Filing | Oct 24, 2016 | — |
| D | Filing | Jul 13, 2016 | — |
| D/A | Filing | Mar 22, 2016 | — |
| D | Filing | Dec 21, 2015 | — |
| EFFECT | Filing | Oct 22, 2015 | — |
| EFFECT | Filing | Oct 22, 2015 | — |
| EFFECT | Filing | Jul 29, 2015 | — |
| CORRESP | Letter to the SEC | Jul 23, 2015 | — |
| CORRESP | Letter to the SEC | Jul 7, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2015 | — |
| D | Filing | Apr 14, 2015 | — |
| D | Filing | Jan 26, 2015 | — |
| EFFECT | Filing | Oct 23, 2014 | — |
| NT 10-K | Filing | Sep 30, 2014 | Jun 30, 2014 |
| EFFECT | Filing | Jul 1, 2014 | — |
| D/A | Filing | Apr 28, 2014 | — |
| D | Filing | Apr 14, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2014 | — |
| PRER14C | Filing | Apr 8, 2014 | — |
| CORRESP | Letter to the SEC | Apr 7, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2014 | — |
| D | Filing | Jan 14, 2014 | — |
| RW | Filing | Dec 19, 2013 | — |
| SC 14F1 | Filing | Jan 14, 2013 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2012 | — |
| CORRESP | Letter to the SEC | Dec 13, 2012 | — |
| PRER14C | Filing | Dec 13, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2012 | — |
| NT 10-Q | Filing | Nov 14, 2012 | Sep 30, 2012 |
| NT 10-K | Filing | Oct 1, 2012 | Jun 30, 2012 |
| 8-A12G | Form 8-a12g | Sep 9, 2011 | — |
| EFFECT | Filing | Aug 12, 2011 | — |
| CORRESP | Letter to the SEC | Aug 11, 2011 | — |
| CORRESP | Letter to the SEC | Aug 11, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2011 | — |
| CORRESP | Letter to the SEC | Jul 20, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2011 | — |
| D | Filing | May 17, 2011 | — |
Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RZLT (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Redwood City, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509261
- Former names
- AntriaBio, Inc. (until Dec 7, 2017); FITS MY STYLE INC (until Jan 11, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.